We are monitoring the impact of COVID-19 on Infectious Diseases Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4449
Share on
Share on

Global Infectious Diseases Diagnostics Market Analysis - By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) & By Region - Industry Size, Share, Growth, Trends & Forecast (2019 - 2024)

Pulished: February, 2020
ID: 4449
Pages: 170

Global Infectious Disease Diagnostics Market Size & Growth (2019 – 2024)

The size of the Infectious Diseases Diagnostics Market at a global level is anticipated to grow at a 7.9% CAGR from 2019 to 2024 and it is estimated that the global market was valued at USD 16.82 billion in 2019 and is relied upon to achieve USD 24.6 billion by 2024 during the forecast period 2019-2024.

Infectious disease diagnostics involves various methods to check for the presence of foreign antigen/organism with the help of numerous diagnostic tools. Infectious disease conditions are highly widespread in underdeveloped regions owing to the lack of awareness for personal hygiene, minimal health care expenditures, and the absence of efficient physician services. Rising cases of infectious diseases in developed economies are further expected to boost market growth. This has lead vitro diagnostic device manufacturers to invest in emerging economies. These companies are taking efforts to develop and commercialize cost-effective tools for infectious disease diagnosis.

Disease diagnostics are used for confirmation of the disease in the form of a quick, precise test result. Being time-consuming, disease diagnostics are on a rise. The infectious disease epidemics are spreading worldwide, thereby leading to an increase in demand for diagnostic tests. In addition, the incidences of malaria, flu, AIDS, and other diseases are also on a rise, creating a robust demand for infectious disease diagnostics.

With a majority of physicians adopting the evidence-based treatment method, infectious disease diagnostic kits are more likely to gain traction over the forecast period. Several government-funded programs all over the globe are increasingly providing free screening and tests in order to increase awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to boost the market growth in the next few years.

The rise in the prevalence of infectious diseases such as HIV, hepatitis, and others are creating lucrative growth opportunities to key market players in the global infectious disease diagnostics market. Increasing demand for point of care testing systems is anticipated to offer a number of growth opportunities for the stakeholders operating in the infectious disease diagnostics market during the forecast period. Increasing economies of developed and developing nations such as the US, Brazil, Canada, India, China led to the expansion of healthcare providing number of opportunities to the key players in the infectious disease diagnostics business.

The increasing need to develop novel and useful diagnostic techniques owing to the consistently rising population diagnosed with contagious diseases are supposed to provide lucrative opportunities for the growth of infectious disease diagnostics market during the outlook period. The emergence of faster and reliable diagnostic techniques and the equipment integrated with artificial intelligence and machine learning are offering growth opportunities for the global infectious disease diagnostics market.

However, diagnostic kits are expensive and manufacturers still have a poor distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to rapid revenue growth of the global infectious diseases diagnostics market.

Key happenings in this market in the recent past:

  • In 2019, Abbott laboratories have launched a novel product called Alinity m diagnostic system. The product is applied to enhance the molecular diagnostic testing by reducing the span and number of instruments needed for the trial; owing to this, a large number of tests can be conducted in shorter timeframes.
  • A research team from the National University of Singapore has developed an effective technology called envision for detecting diseases in very less time frame. Envision has the potential to identify the disease and its subtypes at low costs and faster rates. The results of the tests are easily accessible to patients and can be analyzed by smartphones, an ideal feature that makes reliable device telemedicine.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Modality, Technology Solutions, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Analysed

Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, Becton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.

 

This research report on Global Infectious Diseases Diagnostics Market has been segmented and sub-segmented into the following categories and evaluated market size and forecast for each segment until 2024.

Infectious Diseases Diagnostics Market Analysis - By Product:

  • Instruments
  • Reagents
  • Services
  • Software

Infectious Diseases Diagnostics Market Analysis - By Application:

  • Hepatitis B
  • Hepatitis C
  • Human Immunodeficiency Virus (HIV)
  • Tuberculosis (TB)
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae (CT/NG)
  • Human papillomavirus (HPV)
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • and others (Influenza, Ebola, Typhoid, Malaria, and Dengue)

On the basis of application, the Hepatitis B segment is contributing a significant share of revenues to the global market due to high prevalence of the disease and increased adoption of advanced diagnostics methods for Hepatitis B. HIV, tuberculosis, influenza is overgrowing at a high pace and is expected to contribute a significant share to the global infectious diagnostics market during the estimated period.

Infectious Diseases Diagnostics Market Analysis - By Technology:

  • PCR
  • INAAT
  • DNA Sequencing
  • Hybridization

On the basis of technology, the DNA Sequencing segment is contributing the largest share of revenues to the global market and is likely to display growth at high CAGR during the forecast period due to cost reduction and technological improvements of next-generation sequencing.

 Infectious Diseases Diagnostics Market Analysis - By Traditional methods:

  • Immunodiagnostics
  • Microscopy
  • Biochemical Characterization

Infectious Diseases Diagnostics Market Analysis - By End User:

  • Hospital
  • Laboratories

On the basis of end-user, the hospital segment is leading the market owing to the factors such as reimbursements offered by the governments, accessibility to the patients, availability of advanced diagnostics equipment in the hospitals, high flow of patients in hospitals. Laboratory segment is contributing a significant share to the market and is likely to continue the trend during the forecast period owing to the increasing adoption of automated diagnostics technologies in laboratories such as mass spectrometry, and PCR. 

Regional Analysis:

North America held the largest share of the IDD market, followed by Europe. Both regions are projected to witness single-digit growth rates during the coming years.

Be that as it may, Asia-Pacific is projected to register the highest growth rate in the coming years, due to the high pervasiveness of infectious diseases, and huge investment opportunities due to a growth in healthcare expenditure.

Some of the prominent companies dominating the Global Infectious Diseases Diagnostics Market profiled in the report are:

  1. Abbott Laboratories
  2. bioMérieux SA
  3. Hologic, Inc.
  4. Danaher Corporation
  5. Becton, Dickinson, and Company
  6. Cepheid, Inc.
  7. Thermo Fisher Scientific Inc.
  8. Roche Diagnostics
  9. Alere Inc
  10. DiaSorin S.p.A
  11. Quidel Corporation
  12. Bio-Rad Laboratories, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2  Instruments & Analyzers 

                                5.1.3 Consumables         

                                                5.1.3.1 Assays and Reagents

                                5.1.4 Services & Softwares          

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 Technique                   

                                5.2.1 Introduction           

                                5.2.2 Traditional Diagnostic Techniques 

                                                5.2.2.1 Immunodiagnostics

                                                5.2.2.2  Microscopy

                                                5.2.2.3 Biochemical Characterization

                                5.2.3 Molecular Diagnostics        

                                                5.2.3.1 PCR

                                                5.2.3.2 INAAT

                                                5.2.3.2 Hybridization

                                                5.2.3.3 DNA Sequencing & NGS 

                                                5.2.3.4 Microarray

                                                5.2.3.5 Others

                                5.2.4 Y-o-Y Growth Analysis, By Technique          

                                5.2.5 Market Attractiveness Analysis, By Technique        

                                5.2.6 Market Share Analysis, By Technique          

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Hepatitis B               

                                5.3.3 Hepatitis C               

                                5.3.4 Human Immunodeficiency Virus (HIV)        

                                5.3.5 Tuberculosis (TB)  

                                5.3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)            

                                5.3.7 Human papillomavirus (HPV)          

                                5.3.8 Methicillin-resistant Staphylococcus aureus (MRSA)            

                                5.3.9 Others      

                                5.3.10 Y-o-Y Growth Analysis, By Application      

                                5.3.11  Market Attractiveness Analysis, By Application   

                                5.3.12  Market Share Analysis, By Application     

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  Laboratories       

                                5.4.3 Physician office Labs           

                                5.4.4  Academics              

                                5.4.5 Others      

                                5.4.6 Y-o-Y Growth Analysis, By End User             

                                5.4.7  Market Attractiveness Analysis, By End User          

                                5.4.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Technique

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Technique

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Technique

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Laboratories               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 bioMérieux SA                          

                8.3 Hologic Inc.                 

                8.4 Danaher Corporation                             

                8.5 Sbecton                       

                8.6 Dickinson and Company                        

                8.7 Cepheid Inc.                               

                8.8 Thermo Fisher Scientific Inc.               

                8.9 Roche Diagnostics                    

                8.10 Alere Inc.                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Infectious Diseases Diagnostics  Market By Region, From 2019-2024 ( USD Billion )
  2. Global Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  3. Global Instruments Market By Region, From 2019-2024 ( USD Billion )
  4. Global Reagents Market By Region, From 2019-2024 ( USD Billion )
  5. Global Services Market By Region, From 2019-2024 ( USD Billion )
  6. Global Software Market By Region, From 2019-2024 ( USD Billion )
  7. Global Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  8. Global Hepatitis B Market By Region, From 2019-2024 ( USD Billion )
  9. Global Hepatitis C Market By Region, From 2019-2024 ( USD Billion )
  10. Global Human Immunodeficiency Virus (HIV) Market By Region, From 2019-2024 ( USD Billion )
  11. Global Tuberculosis (TB) Market By Region, From 2019-2024 ( USD Billion )
  12. Global Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market By Region, From 2019-2024 ( USD Billion )
  13. Global human papillomavirus (HPV) Market By Region, From 2019-2024 ( USD Billion )
  14. Global Methicillin-resistant Staphylococcus aureus (MRSA) Market By Region, From 2019-2024 ( USD Billion )
  15. Global Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  16. Global PCR Market By Region, From 2019-2024 ( USD Billion )
  17. Global INAAT Market By Region, From 2019-2024 ( USD Billion )
  18. Global DNA Sequencing Market By Region, From 2019-2024 ( USD Billion )
  19. Global Hybridization Market By Region, From 2019-2024 ( USD Billion )
  20. Global Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  21. Global Laboratories Market By Region, From 2019-2024 ( USD Billion )
  22. Global Hospital Market By Region, From 2019-2024 ( USD Billion )
  23. North America Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  24. North America Instruments Market By Region, From 2019-2024 ( USD Billion )
  25. North America Reagents Market By Region, From 2019-2024 ( USD Billion )
  26. North America Services Market By Region, From 2019-2024 ( USD Billion )
  27. North America Software Market By Region, From 2019-2024 ( USD Billion )
  28. North America Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  29. North America Hepatitis B Market By Region, From 2019-2024 ( USD Billion )
  30. North America Hepatitis C Market By Region, From 2019-2024 ( USD Billion )
  31. North America Human Immunodeficiency Virus (HIV) Market By Region, From 2019-2024 ( USD Billion )
  32. North America Tuberculosis (TB) Market By Region, From 2019-2024 ( USD Billion )
  33. North America Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market By Region, From 2019-2024 ( USD Billion )
  34. North America human papillomavirus (HPV) Market By Region, From 2019-2024 ( USD Billion )
  35. North America Methicillin-resistant Staphylococcus aureus (MRSA) Market By Region, From 2019-2024 ( USD Billion )
  36. North America Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  37. North America PCR Market By Region, From 2019-2024 ( USD Billion )
  38. North America INAAT Market By Region, From 2019-2024 ( USD Billion )
  39. North America DNA Sequencing Market By Region, From 2019-2024 ( USD Billion )
  40. North America Hybridization Market By Region, From 2019-2024 ( USD Billion )
  41. North America Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  42. North America Laboratories Market By Region, From 2019-2024 ( USD Billion )
  43. North America Hospital Market By Region, From 2019-2024 ( USD Billion )
  44. United States Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  45. United States Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  46. United States Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  47. United States Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  48. Canada Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  49. Canada Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  50. Canada Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  51. Canada Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  52. Europe Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  53. Europe Instruments Market By Region, From 2019-2024 ( USD Billion )
  54. Europe Reagents Market By Region, From 2019-2024 ( USD Billion )
  55. Europe Services Market By Region, From 2019-2024 ( USD Billion )
  56. Europe Software Market By Region, From 2019-2024 ( USD Billion )
  57. Europe Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  58. Europe Hepatitis B Market By Region, From 2019-2024 ( USD Billion )
  59. Europe Hepatitis C Market By Region, From 2019-2024 ( USD Billion )
  60. Europe Human Immunodeficiency Virus (HIV) Market By Region, From 2019-2024 ( USD Billion )
  61. Europe Tuberculosis (TB) Market By Region, From 2019-2024 ( USD Billion )
  62. Europe Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market By Region, From 2019-2024 ( USD Billion )
  63. Europe human papillomavirus (HPV) Market By Region, From 2019-2024 ( USD Billion )
  64. Europe Methicillin-resistant Staphylococcus aureus (MRSA) Market By Region, From 2019-2024 ( USD Billion )
  65. Europe Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  66. Europe PCR Market By Region, From 2019-2024 ( USD Billion )
  67. Europe INAAT Market By Region, From 2019-2024 ( USD Billion )
  68. Europe DNA Sequencing Market By Region, From 2019-2024 ( USD Billion )
  69. Europe Hybridization Market By Region, From 2019-2024 ( USD Billion )
  70. Europe Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  71. Europe Laboratories Market By Region, From 2019-2024 ( USD Billion )
  72. Europe Hospital Market By Region, From 2019-2024 ( USD Billion )
  73. U.K. Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  74. U.K. Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  75. U.K. Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  76. U.K. Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  77. Germany Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  78. Germany Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  79. Germany Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  80. Germany Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  81. France Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  82. France Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  83. France Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  84. France Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  85. Italy Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  86. Italy Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  87. Italy Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  88. Italy Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  89. Spain Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  90. Spain Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  91. Spain Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  92. Spain Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  93. Asia Pacific Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  94. Asia Pacific Instruments Market By Region, From 2019-2024 ( USD Billion )
  95. Asia Pacific Reagents Market By Region, From 2019-2024 ( USD Billion )
  96. Asia Pacific Services Market By Region, From 2019-2024 ( USD Billion )
  97. Asia Pacific Software Market By Region, From 2019-2024 ( USD Billion )
  98. Asia Pacific Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  99. Asia Pacific Hepatitis B Market By Region, From 2019-2024 ( USD Billion )
  100. Asia Pacific Hepatitis C Market By Region, From 2019-2024 ( USD Billion )
  101. Asia Pacific Human Immunodeficiency Virus (HIV) Market By Region, From 2019-2024 ( USD Billion )
  102. Asia Pacific Tuberculosis (TB) Market By Region, From 2019-2024 ( USD Billion )
  103. Asia Pacific Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market By Region, From 2019-2024 ( USD Billion )
  104. Asia Pacific human papillomavirus (HPV) Market By Region, From 2019-2024 ( USD Billion )
  105. Asia Pacific Methicillin-resistant Staphylococcus aureus (MRSA) Market By Region, From 2019-2024 ( USD Billion )
  106. Asia Pacific Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  107. Asia Pacific PCR Market By Region, From 2019-2024 ( USD Billion )
  108. Asia Pacific INAAT Market By Region, From 2019-2024 ( USD Billion )
  109. Asia Pacific DNA Sequencing Market By Region, From 2019-2024 ( USD Billion )
  110. Asia Pacific Hybridization Market By Region, From 2019-2024 ( USD Billion )
  111. Asia Pacific Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  112. Asia Pacific Laboratories Market By Region, From 2019-2024 ( USD Billion )
  113. Asia Pacific Hospital Market By Region, From 2019-2024 ( USD Billion )
  114. Japan Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  115. Japan Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  116. Japan Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  117. Japan Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  118. China Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  119. China Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  120. China Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  121. China Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  122. India Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  123. India Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  124. India Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  125. India Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  126. Australia Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  127. Australia Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  128. Australia Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  129. Australia Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  130. South Korea Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  131. South Korea Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  132. South Korea Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  133. South Korea Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  134. Latin America Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  135. Latin America Instruments Market By Region, From 2019-2024 ( USD Billion )
  136. Latin America Reagents Market By Region, From 2019-2024 ( USD Billion )
  137. Latin America Services Market By Region, From 2019-2024 ( USD Billion )
  138. Latin America Software Market By Region, From 2019-2024 ( USD Billion )
  139. Latin America Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  140. Latin America Hepatitis B Market By Region, From 2019-2024 ( USD Billion )
  141. Latin America Hepatitis C Market By Region, From 2019-2024 ( USD Billion )
  142. Latin America Human Immunodeficiency Virus (HIV) Market By Region, From 2019-2024 ( USD Billion )
  143. Latin America Tuberculosis (TB) Market By Region, From 2019-2024 ( USD Billion )
  144. Latin America Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market By Region, From 2019-2024 ( USD Billion )
  145. Latin America human papillomavirus (HPV) Market By Region, From 2019-2024 ( USD Billion )
  146. Latin America Methicillin-resistant Staphylococcus aureus (MRSA) Market By Region, From 2019-2024 ( USD Billion )
  147. Latin America Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  148. Latin America PCR Market By Region, From 2019-2024 ( USD Billion )
  149. Latin America INAAT Market By Region, From 2019-2024 ( USD Billion )
  150. Latin America DNA Sequencing Market By Region, From 2019-2024 ( USD Billion )
  151. Latin America Hybridization Market By Region, From 2019-2024 ( USD Billion )
  152. Latin America Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  153. Latin America Laboratories Market By Region, From 2019-2024 ( USD Billion )
  154. Latin America Hospital Market By Region, From 2019-2024 ( USD Billion )
  155. Brazil Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  156. Brazil Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  157. Brazil Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  158. Brazil Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  159. Argentina Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  160. Argentina Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  161. Argentina Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  162. Argentina Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  163. Mexico Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  164. Mexico Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  165. Mexico Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  166. Mexico Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  167. Rest of Latin America Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  168. Rest of Latin America Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  169. Rest of Latin America Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  170. Rest of Latin America Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  171. Middle East and Africa Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  172. Middle East and Africa Instruments Market By Region, From 2019-2024 ( USD Billion )
  173. Middle East and Africa Reagents Market By Region, From 2019-2024 ( USD Billion )
  174. Middle East and Africa Services Market By Region, From 2019-2024 ( USD Billion )
  175. Middle East and Africa Software Market By Region, From 2019-2024 ( USD Billion )
  176. Middle East and Africa Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  177. Middle East and Africa Hepatitis B Market By Region, From 2019-2024 ( USD Billion )
  178. Middle East and Africa Hepatitis C Market By Region, From 2019-2024 ( USD Billion )
  179. Middle East and Africa Human Immunodeficiency Virus (HIV) Market By Region, From 2019-2024 ( USD Billion )
  180. Middle East and Africa Tuberculosis (TB) Market By Region, From 2019-2024 ( USD Billion )
  181. Middle East and Africa Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market By Region, From 2019-2024 ( USD Billion )
  182. Middle East and Africa human papillomavirus (HPV) Market By Region, From 2019-2024 ( USD Billion )
  183. Middle East and Africa Methicillin-resistant Staphylococcus aureus (MRSA) Market By Region, From 2019-2024 ( USD Billion )
  184. Middle East and Africa Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  185. Middle East and Africa PCR Market By Region, From 2019-2024 ( USD Billion )
  186. Middle East and Africa INAAT Market By Region, From 2019-2024 ( USD Billion )
  187. Middle East and Africa DNA Sequencing Market By Region, From 2019-2024 ( USD Billion )
  188. Middle East and Africa Hybridization Market By Region, From 2019-2024 ( USD Billion )
  189. Middle East and Africa Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  190. Middle East and Africa Laboratories Market By Region, From 2019-2024 ( USD Billion )
  191. Middle East and Africa Hospital Market By Region, From 2019-2024 ( USD Billion )
  192. Middle East Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  193. Middle East Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  194. Middle East Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  195. Middle East Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )
  196. Africa Infectious Diseases Diagnostics  Market By Product, From 2019-2024 ( USD Billion )
  197. Africa Infectious Diseases Diagnostics  Market By  Application, From 2019-2024 ( USD Billion )
  198. Africa Infectious Diseases Diagnostics  Market By Technology, From 2019-2024 ( USD Billion )
  199. Africa Infectious Diseases Diagnostics  Market By  End User , From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample